NCT06823375 2026-03-04
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Chinese University of Hong Kong
Phase 2 Recruiting
Clinical Trials
3 trialsNCT06463444 2024-06-17
Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models
Tongji Hospital
Phase 1 Recruiting
NCT06413017 2024-05-14
Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting